Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Gavel on flag The bipartisan proposal has gone through the Senate Finance Committee but there hasn’t been a vote on it, with no sign that there ever will be. (Photo: Shutterstock)

The Prescription Drug Pricing Act, a joint effort between Senator Chuck Grassley, R-IA, and Senator Ron Wyden, D-OR, has been sitting in limbo on the Senate’s legislative calendar “for months,” according to a Health Care Finance News.

But if it ever made it to an actual vote, the Congressional Budget Office has estimated that it could save more than $94 billion over the course of the next 10 years.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

Marlene Satter

Marlene Y. Satter has worked in and written about the financial industry for decades.

More from this author



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2022 ALM Global, LLC. All Rights Reserved.